We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Supportive Expressive Therapy for Depressed and Anxious Adolescents

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00381979
Recruitment Status : Completed
First Posted : September 28, 2006
Last Update Posted : October 22, 2015
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of the study is to investigate the effectiveness of providing Supportive Expressive Therapy to adolescents who are depressed and/or anxious.

Condition or disease Intervention/treatment
Depression Anxiety Other: Supportive Expressive Therapy

Detailed Description:
Supportive Expressive Therapy (SET; a 16 session manualized form of psychodynamic therapy) has been well utilized with adult clients. To date, there is no known systematic study into the benefit of this method of therapy with adolescents who are depressed and/or anxious. It is thought that SET would be useful for this population as it is similar in principle to Interpersonal Relationship Therapy (IPT), which has been shown to be effective for use with depressed adults and youth. Both IPT and SET help clients explore the role they play within challenging relationships in their lives. SET, however, allows for the exploration of more relationships within the adolescents' circle. Moreover, SET explores the adolescents' perceptions of themselves, others, and their wish in relationships. Further, the SET method is more easily individualized in that it affords greater flexibility in design and possibility for change over time. Accordingly, the purpose of this study is to explore the feasibility of utilizing this method of therapy with adolescents who are depressed and anxious. We will be exploring the effectiveness of SET through the resolution of depressed and/or anxious adolescents' conflictual relationships thereby reducing their symptomatology.

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Supportive Expressive Therapy for Depressed and Anxious Adolescents
Study Start Date : January 2004
Primary Completion Date : October 2007
Study Completion Date : October 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: 1
set
Other: Supportive Expressive Therapy
Other Name: therapy


Outcome Measures

Primary Outcome Measures :
  1. BDI [ Time Frame: pre and post ]
  2. MASC [ Time Frame: pre and post ]
  3. Measures collected at pre, post, and follow-up [ Time Frame: pre and post ]

Secondary Outcome Measures :
  1. YSR [ Time Frame: pre and post ]
  2. CBCL [ Time Frame: pre and post ]
  3. FAM [ Time Frame: pre and post ]
  4. CRI [ Time Frame: pre and post ]
  5. SSRS [ Time Frame: pre and post ]
  6. Measures collected at pre, post, and follow-up [ Time Frame: pre and post ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   15 Years to 24 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 15-24 year old, male & female adolescents, primary diagnosis of depression or anxiety disorder.
  • Clients with co-morbid diagnoses, suicidal ideation or taking medication would not necessarily be excluded if deemed able to partake in the proposed therapy.
  • Medication dose needs to be stable for 4-6 weeks prior to starting therapy.

Exclusion Criteria:

  • Clients who are actively psychotic, developmentally delayed, or have a diagnosis of bipolar disorder.
  • Clients who are not fluent in English.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00381979


Locations
Canada, Ontario
Centre for Addiction and Mental Health
Toronto, Ontario, Canada, M5T1R8
Sponsors and Collaborators
Centre for Addiction and Mental Health
More Information

Responsible Party: Pamela Wilansky-Traynor, psychologist, Centre for Addiction and Mental Health
ClinicalTrials.gov Identifier: NCT00381979     History of Changes
Other Study ID Numbers: 169/2003
First Posted: September 28, 2006    Key Record Dates
Last Update Posted: October 22, 2015
Last Verified: September 2015

Keywords provided by Pamela Wilansky-Traynor, Centre for Addiction and Mental Health:
Depression
Anxiety
Adolescents
Treatment
Supportive Expressive Therapy

Additional relevant MeSH terms:
Depression
Behavioral Symptoms